Skip to main content
. 2024 Mar 29;12(7):745. doi: 10.3390/healthcare12070745

Table 2.

Healthcare utilization trend among the total cohort (N = 160).

Outcome 12-Month
PRE-Implant
Median/Mean +/− Std (95% CI)
12-Month
POST-Implant
Median/Mean +/− Std (95% CI)
Change p-Value
Opioid use measured by MME 42/51.0 +/− 41.6 (42.80–59.32) 20/26.5 +/− 32.1 (20.14–32.90) −24.5 <0.0001 *
ED visits 0/0.12 +/− 0.4 (0.05–0.18) 0/0.03 +/− 0.2 (0.00–0.06) −0.09 0.01 *
Outpatient visits (interventional pain procedures) 1/1.39 +/− 1.8 (1.10–1.67) 0/0.28 +/− 0.6 (0.19–0.36) −1.11 <0.0001 *

(*) Denotes statistically significant value; (−) denotes reduction in mean values. Caption: MME (morphine milligram equivalent); ED (emergency department).